INSECTICID Insecticides (India) Q1 FY26 results (Apr–Jun 2025) and concall
Insecticides (India) Limited delivered strong Q1 FY26 results, with significant growth in revenue, EBITDA, and PAT, primarily driven by its premiumization strategy and new product launches. Despite uneven monsoon patterns impacting certain crop segments and muted B2B sales, the company maintained healthy margins and is optimistic about future growth, supported by capacity expansion and strategic partnerships.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|
| Revenue | 627 | 358 | 359 | 691 |
| EBITDA | 90 | 31 | 28 | 85 |
| Net profit | 61 | 17 | 14 | 58 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
